A second analyst voices positive thoughts on Viking's new GLP-1 weight loss drug. Phase 3 clinical trial data on VK2735 arrives later this year, and phase 2 data on a GLP-1 pill could come out as ...

Both Pfizer and Viking aim to enter the high-growth weight loss drug market. Analysts forecast this market could be worth as much as $130 billion just a few years from now. Big pharmaceutical ...

As he slowly came to grips the fact that the Vikings had failed to accomplish their ultimate goal last season, edge rusher Jonathan Greenard whipped out his phone and unleashed a stream of ...

Our website, archdigest.com, offers constant original coverage of the interior design and architecture worlds, new shops and products, travel destinations, art and cultural events, celebrity style ...

Kwesi Adofo-Mensah, the Minnesota Vikings’ general manager, was not in a reflective mood Saturday afternoon. He’d been asked how the draft punctuated the vision he and the rest of the team ...

Various prominent entities are smacking the Minnesota Vikings around after an NFL draft that was probably never going to reach stellar status in the context of the franchise’s history.

The Minnesota Vikings have moved forward with their preparations for minicamp as media outlets continue to decipher each NFL team’s 2025 NFL Draft. Minnesota started with just four picks but ...

It behooves the Minnesota Vikings to improve the secondary, and a potential trade partner with a proven cornerback could fit the bill. While the Vikings “would have to restructure contracts to ...

Kristina Killgrove is a staff writer at Live Science with a focus on archaeology and paleoanthropology news. Her articles have also appeared in venues such as Forbes, Smithsonian, and Mental Floss.

On Thursday night, Minnesota Vikings general manager Kwesi Adofo-Mensah was asked about his thought process with having only four picks in the 2025 NFL Draft. He quipped: “Wait, we only have ...

Shares of up-and-coming weight loss drug developers Viking Therapeutics (NASDAQ:VKTX), Metsera (NASDAQ:MTSR), and Structure Therapeutics (NASDAQ:GPCR) traded sharply higher after Pfizer (NYSE ...

The Minnesota Vikings played the long game in replenishing their quarterback room following the departures of Sam Darnold to the Seattle Seahawks, Daniel Jones to the Indianapolis Colts and Nick ...